Overview

Antiarrhythmics Versus Implantable Defibrillators (AVID)

Status:
Completed
Trial end date:
2002-08-01
Target enrollment:
Participant gender:
Summary
To evaluate if use of an implantable cardiac defibrillator (ICD) results in reduction in total mortality, when compared with conventional pharmacological therapy, in patients resuscitated from sudden cardiac death who are otherwise at very high risk of mortality from arrhythmic causes.
Phase:
Phase 3
Details
Lead Sponsor:
National Heart, Lung, and Blood Institute (NHLBI)
Treatments:
Amiodarone
Sotalol